NOTCH1 and neoplasm: One previous whole-exome sequencing (WES) study of 55 PSCCE revealed disruption of putative tumor-suppressors including TP53 (80%), RB1 (27%), and NOTCH1 (24%), claiming that PSCCE genetically resembled ESCC11.